胸段食管鳞状细胞癌中左气管支气管淋巴结清扫的临床意义
研究纳入3522例接受食管切除术的食管鳞状细胞癌患者,608例接受左气管支气管淋巴结清扫,其中45例(7.4%)存在该站转移。倾向性评分匹配后,清扫组5年总生存优于未清扫组(68.2% vs 64.6%,P = .012);清扫组内有转移者生存显著差于无转移者(40.5% vs 62.2%,P = .029)。临床T分期和肿瘤分化是左气管支气管淋巴结转移的独立危险因素。
要点
- 左气管支气管淋巴结转移者5年总生存40.5% vs 无转移者62.2%,P = .029。
- 倾向性评分匹配后清扫组5年总生存68.2% vs 未清扫组64.6%,P = .012。
- 临床T分期和肿瘤分化是左气管支气管淋巴结转移的独立危险因素。
核心结论
- 胸段食管鳞状细胞癌中,左气管支气管淋巴结转移提示预后不良,左气管支气管淋巴结清扫似乎与更有利的预后相关。
- 临床T分期和肿瘤分化是左气管支气管淋巴结转移的独立危险因素。
- 作者认为,对于高风险患者,应行常规预防性左气管支气管淋巴结清扫。
研究设计与样本
- 回顾性纳入3522例接受食管切除术的食管鳞状细胞癌患者。
- 采用Kaplan-Meier法计算总生存,log-rank检验比较,并行倾向性评分匹配调整混杂因素。
- 采用单因素和多因素logistic回归分析识别左气管支气管淋巴结转移的独立危险因素。
主要发现
- 608例患者接受了左气管支气管淋巴结清扫,其中45例存在左气管支气管淋巴结转移(7.4%)。
- 倾向性评分匹配后,接受左气管支气管淋巴结清扫患者的5年总生存优于未接受清扫者(68.2% vs 64.6%,P = .012)。
- 在接受左气管支气管淋巴结清扫的患者中,有左气管支气管淋巴结转移者的生存显著差于无转移者(5年总生存:40.5% vs 62.2%,P = .029)。
- 多因素logistic分析显示,临床T分期和肿瘤分化是左气管支气管淋巴结转移的独立危险因素。
临床怎么用
- 作者认为,对于高风险患者,应行常规预防性左气管支气管淋巴结清扫。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The left tracheobronchial lymph nodes are considered as regional lymph nodes for esophageal squamous cell carcinoma, but routine prophylactic left tracheobronchial lymph node dissection for all resectable esophageal squamous cell carcinoma has been controversial. This study aimed to evaluate the prognostic impact of left tracheobronchial lymph node dissection and left tracheobronchial lymph node metastases in thoracic esophageal squamous cell carcinoma and to analyze the risk factors of left tracheobronchial lymph node metastases. METHODS: A total of 3522 patients with esophageal squamous cell carcinoma undergoing esophagectomy were included. Overall survival was calculated by a Kaplan-Meier method and compared using the log-rank test. Propensity score matching was conducted to adjust confounding factors. Univariable and multivariable logistic regression analyses were used to identify independent risk factors of left tracheobronchial lymph node metastases. RESULTS: In this study, 608 patients underwent left tracheobronchial lymph node dissection and 45 patients had left tracheobronchial lymph node metastases (7.4%). After propensity score matching, the 5-year overall survival in patients receiving left tracheobronchial lymph node dissection was better than in patients who did not (68.2% vs 64.6%, P = .012). In patients receiving left tracheobronchial lymph node dissection, patients with left tracheobronchial lymph node metastases had a significantly poorer survival than patients without (5-year overall survival: 40.5% vs 62.2%, P = .029). Multivariable logistic analyses showed that clinical T stage and tumor differentiation were independent risk factors for left tracheobronchial lymph node metastases. CONCLUSIONS: In thoracic esophageal squamous cell carcinoma, station left tracheobronchial lymph node metastases indicate a poor prognosis and left tracheobronchial lymph nodes dissection seems to be associated with a more favorable prognosis. Clinical T stage and tumor differentiation were independent risk factors for left tracheobronchial lymph node metastases. For patients with high risk, routine prophylactic left tracheobronchial lymph node dissection should be performed.
引用
- Xu L, Wei XF, Chen XK, et al. Clinical significance of left tracheobronchial lymph node dissection in thoracic esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2022. PMID: 35400494. doi:10.1016/j.jtcvs.2022.02.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。